Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

CD79 Expression Is Associated with Cell-of-Origin and Outcome in Diffuse Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 1760.

https://doi.org/10.1182/blood-2023-172972

Published: 2023

Journal Articles

Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

Blood (2022) 140 (Supplement 1): 6421–6423.

https://doi.org/10.1182/blood-2022-157702

Published: 2022

Journal Articles

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Blood (2019) 134 (Supplement_1): 4587.

https://doi.org/10.1182/blood-2019-124634

Published: 2019

Journal Articles

Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707

Yoshinobu Maeda, MD PhD, Hisakazu Nishimori, MD PhD, Yasushi Hiramatsu, Isao Yoshida, Masatoshi Uno, Yasufumi Masaki, MD PhD, Kazutaka Sunami, MD PhD, Taro Masunari, Yuichiro Nawa, Hiroshi Gomyo, Hiromichi Yamane, Tsutomu Takahashi, MD PhD, Tomofumi Yano, Hidetaka Takimoto, MD, Keitaro Matsuo, MD PhD, Tadashi Yoshino, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 5349.

https://doi.org/10.1182/blood.V128.22.5349.5349

Published: 2016

Journal Articles

A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Blood (2015) 126 (23): 2680.

https://doi.org/10.1182/blood.V126.23.2680.2680

Published: 2015

Journal Articles

Outcome After First Relapse In Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Shinichi Kako, MD, Heiwa Kanamori, MD, Naoki Kobayashi, MD, Akio Shigematsu, MD, Yasuhito Nannya, MD, Mika Nakamae, M.D., Ph.D, Kazuyuki Shigeno, MD, Kazumi Suzukawa, MD, Masahiro Takeuchi, MD, Motohiro Tsuzuki, MD, Kensuke Usuki, MD, Kazuo Hatanaka, MD, Kazuei Ogawa, MD, Kinuko Mitani, MD, Yuichiro Nawa, MD, Yoshihiro Hatta, MD, Ishikazu Mizuno, MD, Yoshinobu Kanda, MD

Blood (2011) 118 (21): 3084.

https://doi.org/10.1182/blood.V118.21.3084.3084

Published: 2011

Journal Articles

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Naoyuki Uchida, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Masato Watanabe, Kazuaki Yakushiji, Shingo Yano, Yuichiro Nawa, Jun Taguchi, Jin Takeuchi, Junji Tomiyama, Yuko Nakamura, Ikuo Miura, Yoshinobu Kanda, Yoichi Takaue, Takahiro Fukuda

Blood (2011) 117 (7): 2113–2120.

https://doi.org/10.1182/blood-2010-05-285502

Published: 2011

Includes: Supplemental data

Journal Articles

Utility of Positron Emission Tomography/Computed Tomography In Extranodal Natural Killer/T-Cell Lymphoma

Hideaki Fujiwara, Yoshinobu Maeda, Yuichiro Nawa, Masayuki Yamakura, Daisuke Ennishi, Yukihiro Miyazaki, M.D., Katsuji Shinagawa, Masamichi Hara, Mitsune Tanimoto, Kosei Matsue

Blood (2010) 116 (21): 3101.

https://doi.org/10.1182/blood.V116.21.3101.3101

Published: 2010

Journal Articles

A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?.

Blood (2009) 114 (22): 2281.

https://doi.org/10.1182/blood.V114.22.2281.2281

Published: 2009

Journal Articles

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.

Saiko Kurosawa, Takuhiro Yamaguchi, Naoyuki Uchida, Toru Sakura, Kensuke Usuki, Masato Watanabe, Takuya Yamashita, Heiwa Kanamori, Junji Tomiyama, Yuichiro Nawa, Shingo Yano, Jin Takeuchi, Kazuaki Yakushiji, Fumiaki Sano, Nobuhiko Uoshima, Yasuhito Nannya, Yoshiyuki Moriuchi, Yoichi Takaue, Takahiro Fukuda

Blood (2009) 114 (22): 524.

https://doi.org/10.1182/blood.V114.22.524.524

Published: 2009

Journal Articles

Clinical Outcome by Acute Graft-Versus Host Disease (GVHD) Prophylaxis in Patients Underwent Allogeneic Bone Marrow Transplantation from Unrelated Donors: Nationwide Survey in Japan.

Masamichi Hara, MD, Toshio Wakayama, MD, Hiroatsu Ago, MD, Teruhiko Kozuka, MD, Yuichiro Nawa, MD, Koji Iwato, MD, Hiroshi Sao, MD, Shinichiro Okamoto, MD, Hisashi Sakamaki, MD, Takakazu Kawase, MD, Yasuo Morishima, MD, Yoshihisa Kodera, MD

Blood (2007) 110 (11): 1960.

https://doi.org/10.1182/blood.V110.11.1960.1960

Published: 2007

Journal Articles

Reduced-Intensity Bone Marrow Transplantation for Heavily Transfused Patients with Severe Aplastic Anemia - Japanese Single Center Experience.

Teruhiko Kozuka, MD, Kazushi Tanimoto, MD, Koichi Nakase, MD, Yuichiro Nawa, MD, Masamichi Hara, MD

Blood (2006) 108 (11): 5384.

https://doi.org/10.1182/blood.V108.11.5384.5384

Published: 2006

Journal Articles

Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) in Japan: An Analysis from West-Japan Hematology/Oncology Group (West-JHOG) NHL Outcomes Project.

Blood (2006) 108 (11): 4698.

https://doi.org/10.1182/blood.V108.11.4698.4698

Published: 2006

Journal Articles

Responses of Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells to Alloantigen Stimulation

Yuichiro Nawa, Takanori Teshima, Kazutaka Sunami, Yasushi Hiramatsu, Tomofumi Yano, Katsuji Shinagawa, Eijiro Omoto, Mine Harada

Blood (1997) 90 (4): 1716–1718.

https://doi.org/10.1182/blood.V90.4.1716b

Published: 1997

NARROW

CD79 Expression Is Associated with Cell-of-Origin and Outcome in Diffuse Large B-Cell Lymphoma

Clinical Impact of Cell-of-Origin and Double-Hit Signature of DLBCL in Japan

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707

A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Outcome After First Relapse In Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission

Utility of Positron Emission Tomography/Computed Tomography In Extranodal Natural Killer/T-Cell Lymphoma

A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?.

Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.

Clinical Outcome by Acute Graft-Versus Host Disease (GVHD) Prophylaxis in Patients Underwent Allogeneic Bone Marrow Transplantation from Unrelated Donors: Nationwide Survey in Japan.

Reduced-Intensity Bone Marrow Transplantation for Heavily Transfused Patients with Severe Aplastic Anemia - Japanese Single Center Experience.

Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) in Japan: An Analysis from West-Japan Hematology/Oncology Group (West-JHOG) NHL Outcomes Project.

Responses of Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells to Alloantigen Stimulation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only